These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 14518724)

  • 61. Contrasting patterns of hepatitis C virus infection in two regions from Tunisia.
    Mejri S; Salah AB; Triki H; Alaya NB; Djebbi A; Dellagi K
    J Med Virol; 2005 Jun; 76(2):185-93. PubMed ID: 15834884
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.
    Noppornpanth S; Lien TX; Poovorawan Y; Smits SL; Osterhaus AD; Haagmans BL
    J Virol; 2006 Aug; 80(15):7569-77. PubMed ID: 16840336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients.
    Peres-da-Silva A; de Almeida AJ; Lampe E
    Arch Virol; 2010 May; 155(5):807-11. PubMed ID: 20405151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
    J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
    Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D
    HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift.
    Gallo M; Bottomley MJ; Pennestri M; Eliseo T; Paci M; Koch U; Bazzo R; Summa V; Carfì A; Cicero DO
    Virology; 2010 Sep; 405(2):424-38. PubMed ID: 20630554
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.
    Mihm S; Monazahian M; Grethe S; Meier V; Thomssen R; Ramadori G
    J Med Virol; 2000 May; 61(1):29-36. PubMed ID: 10745229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
    Kimura Y; Hayashida K; Ishibashi H; Niho Y; Yanagi Y
    J Med Virol; 2000 May; 61(1):37-43. PubMed ID: 10745230
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Selection and characterization of peptides that specifically binding to hepatitis C virus serine protease].
    Du G; Hou L; Chen W; Zhang Y; Wang H
    Wei Sheng Wu Xue Bao; 2002 Jun; 42(3):298-304. PubMed ID: 12557369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.
    Cao Y; Zhang Y; Wang S; Zou W
    Nephrol Dial Transplant; 2009 Sep; 24(9):2745-51. PubMed ID: 19377056
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular models of NS3 protease variants of the Hepatitis C virus.
    da Silveira NJ; Arcuri HA; Bonalumi CE; de Souza FP; Mello IM; Rahal P; Pinho JR; de Azevedo WF
    BMC Struct Biol; 2005 Jan; 5():1. PubMed ID: 15663787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection.
    Wang H; Bian T; Merrill SJ; Eckels DD
    J Mol Evol; 2002 Apr; 54(4):465-73. PubMed ID: 11956685
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cloning and sequencing of partial genes of hepatitis C virus genome in patients with acute hepatitis C].
    Jiang D; Yao D; Dong Z; Qiu L; Lu J
    Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):153-5. PubMed ID: 10880163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.